JBIO
Jade Biosciences, Inc. SEC filings
Every EDGAR filing for Jade Biosciences, Inc. (JBIO), newest first, with AI summaries and stories.
- Ticker
- JBIO
- CIK
- 1798749
- Sector
- Biotech and pharma
- Latest filing
- Sep 30
Next: 10-Q expected ~Nov 12 (deadline Nov 16) · earnings expected ~Nov 13
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINESCHEDULE 13G/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P. (amended)
Venrock Healthcare Capital Partners III, L.P., filed by
ROUTINESCHEDULE 13G/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Bellevue Group AG (amended)
Bellevue Group AG, filed by
NOTABLE10-QJade Biosciences, Inc.JBIOLIVE ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINESCHEDULE 13GJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP, filed by
ROUTINESCHEDULE 13G/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Janus Henderson Group Ltd. (amended)
Janus Henderson Group Ltd., filed by
ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINE4Jade Biosciences, Inc.JBIOLIVE 2 insider filings
Mark Eisner, insider filing for JBIO
Show all 2
- 4Insider filing for JBIO
- 3New insider at JBIO
Mark Eisner, reporting
ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINE4Jade Biosciences, Inc.JBIOLIVE 5 insider filings
Christopher W. Cain, insider filing for JBIO
Show all 5
- 4Insider filing for JBIO
- 4Insider filing for JBIO
- 4Insider filing for JBIO
- 4Insider filing for JBIO
- 4Insider filing for JBIO
Christopher W. Cain, reporting
ROUTINE8-KJade Biosciences, Inc.JBIOLIVE NOTABLESCHEDULE 13D/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Fairmount Funds Management LLC (amended)
Fairmount Funds Management LLC, filed by
ROUTINEDEFA14AJade Biosciences, Inc.JBIOLIVE ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINE424B5Jade Biosciences, Inc.JBIOLIVE ROUTINE424B5Jade Biosciences, Inc.JBIOLIVE ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINEEFFECTJade Biosciences, Inc.JBIOLIVE ROUTINEEFFECTJade Biosciences, Inc.JBIOLIVE ROUTINE424B3Jade Biosciences, Inc.JBIOLIVE ROUTINESCHEDULE 13G/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)
JANUS HENDERSON GROUP PLC, filed by
ROUTINES-8Jade Biosciences, Inc.JBIOLIVE ROUTINES-3Jade Biosciences, Inc.JBIOLIVE ROUTINES-3Jade Biosciences, Inc.JBIOLIVE ROUTINE424B3Jade Biosciences, Inc.JBIOLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B3Securities offering
NOTABLE10-QJade Biosciences, Inc.JBIOLIVE ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINEARSJade Biosciences, Inc.JBIOLIVE ROUTINEDEFA14AJade Biosciences, Inc.JBIOLIVE ROUTINEDEF 14AJade Biosciences, Inc.JBIOLIVE ROUTINESCHEDULE 13G/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINEPRE 14AJade Biosciences, Inc.JBIOLIVE ROUTINE8-KJade Biosciences, Inc.JBIOLIVE ROUTINES-8Jade Biosciences, Inc.JBIOLIVE ROUTINEPOS EXJade Biosciences, Inc.JBIOLIVE ROUTINEPOS EXJade Biosciences, Inc.JBIOLIVE ROUTINE424B3Jade Biosciences, Inc.JBIOLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B3Securities offering
NOTABLE10-KJade Biosciences, Inc.JBIOLIVE ROUTINE8-KJade Biosciences, Inc.JBIOLIVE NOTABLESCHEDULE 13D/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Sofinnova Venture Partners X, L.P. (amended)
Sofinnova Venture Partners X, L.P., filed by
ROUTINESCHEDULE 13G/AJade Biosciences, Inc.JBIOLIVE Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P. (amended)
Venrock Healthcare Capital Partners III, L.P., filed by